I personally will never buy a blue chip company. Small/nano cap...

What do you see? Not familiar with biotechs, I stick to oil&tech, always open minded however

I don't understand why people voluntarily choose to enter the penny stock casino when there are thousands of real, non-shit companies right in front of your face. How much do you all end up paying in trading costs? Most of these tickers trade

Developing supplements that can prevent and cure kidney diseases, like curious, could be big

Scottrade is about 7$ a trade.. I'm sure to trade penny stocks it's a slightly higher fee. Besides that, penny stocks are far from a "casino".. Most are shit company but the few diamonds in the rough give returns that will beat out whatever big companies you have selected. Also, if you judge a company by the spread, you are obviously a very misinformed investor

Interesting, I'd put small money towards something like that to see what happens but never anything serious. Too risky imo

On phone now

How do the vanguard small cap funds compare to large cap funds?

My first guess is they underperform the s&p.

PTN

en.wikipedia.org/wiki/Bremelanotide

>Positive results of bremelanotide in the treatment of hypoactive sexual desire disorder (HSDD) in two late-stage phase III clinical trials were announced by Palatin on 1 November 2016.[3] The company is expected to seek approval of bremelanotide for this indication in the United States in the second half of 2017.[3]

Anyway, its a sexual dysfunction drug that works on both women and men, I've personally tried it and it works (its not illegal to order, just expensive). I invested in this company. IMO its worth a look.

It's a casino.

And considering that the spread is as real of a trading cost as the $7 fee, I'm not understanding how I can be misinformed.

Don't blame you, with this type of stuff

Vanguards small cap fund returned 25% ytd as of last quarter, my guess that it would be one of the leaders
I'm really not understanding what you're trying to get across with the spread. ICPW's spread is less than a cent right now. You can buy .2525 or sell .26. I don't understand how that is a bad thing...

I think your portfolio sucks, and that you lack the dynamic strategy needed for success in a dynamic market.

Tell me why I'm wrong about the portfolio sucking.

If it gets passed, then like any biotech it'll be huge.. But the downside will be significant if it doesn't pass

I held 20k shares of PTN, but sold after their recent partnership was announced. Palatin didn't get what they should have for Bremelanotide, and I have serious reservation about whether a microinjection is a marketable delivery method.

I've started slapping the ask of stocks with small floats early in the trading day, then waiting for investors's scanners or the media to alert them and drive the share price up even more. This method has worked far better than investing in a stock like PTN, which will be dead money for at least another year-and-a-half now that they're already partnered.

tl;dr Sell PTN; it's dead money. I accidentally created huge spikes in the prices of ETRM and OPHC. lol

To start i'm up 40% since April 2016. All the names I own are value except for pbox and as long as they perform during earnings reports I'm making money so market conditions don't affect me that heavily. I do need to diversify but the industries I know the most are oil and tech so I stick in that area

It's in the final phase of FDA trials and will pass; however, there won't be word on that for at least a year-and-a-half. In that time span, it'd be better to invest in other stocks.

I bought after the FDA changed the guidelines for FHSDD in October. That was a huge 'tell' that PTN was going to have a successful P3 trial.

Anyway, the deal they got with AMAG was not a good one for a drug with potential like Bremelanotide does. I urge you to read through this 8k: seekingalpha com/filing/3351320

I'll definitely read through it. How do you pick through your biotechs, sort which company has a higher chance of passing their drug than the other? I'd love to get into them but it seems like a huge gamble to me and I have very little knowledge on the industry

I did the injection, it was easy. I picked up some diabetes needles at a pharmacy and ordered some bacteriostatic injectable water.

I see your point. Blue chips provide a small yield and they are more threatened than ever by upcoming new competitors. Nowadays we live in a world where globalization implies fast materialization of ideas, so companies that can't follow the changes and can't innovate disappear.

My bad , I thought you were the PTN guy.

>Chart says to sell CETEF, but the financials are looking good. I don't know if this will go much higher because of its yuuuuuge float
>ATGN's financials look like garbage
>Hold PERI, hope for better financials, the float is yuuuge though
>LPTH has been in my portfolio on and off the past year; however, I just sold and will rebuy when it dips again.
>PBOX is growing really, really slowly. I don't think there's much upside there.

I'll look at ICPW and BOSC in a second.

CETEF is definitely undervalued based on assets
ATGN's last 2 quarters haven't been stellar, but I'd have to disagree with you on that. Long term for me
PERI & LPTH Ive sold over half my position and I'm holding other half to see what happens with earnings.
PBOX is interesting to me.. Anyone who owns less than 1000 shares gets an 80 cent payout

I don't invest in biotech very often because it's hard to never know when the FDA is going to show its true, corrupt colors and most investors don't understand the science behind pharmaceuticals or the FDA approval process, so the market reacts in really, really stupid ways. For example, Eaglet Corporation (EGLT) got FDA approval for an abuse-deterrent opiate, but lost 40% of its share price since approval. This drop in price is simply investors are reacting to the label of this drug, Arymo, not saying it's orally and nasally abuse deterrent.

Primarily, I learn about the chemistry of a company's pipeline, read the results of their drug studies, and look to poke holes in their data and science as much as possible. I also attend 15-20 biotech conference calls per months and take notes on what I hear. Researching biotechs are a bitch, user.

Sounds like it.. I doubt I'll ever be in one

Slow but safe. Small names come with a higher degree of risk but much higher returns

*...hard to know when the FDA...

I thought faster than I wrote & combined "you never know" with "it's hard to know when". Don't you hate when that happens?

BOSC looks like a value trap. What am I missing, do they have a dividend like PBOX?

I must be missing something with ICPW, too. The most recent financials look really, really bad and would be a red flag for me.

Hey user, if you want a good swing trade, look at CRDS. That thing should fly in the next couple days; also, immediately take your profits when it does.

Yes, but if I could make a suggestion: look at the share float before pulling the trigger because the float directly correlates to future growth showing up in share price.

PBOX is interesting. It's a one time pay out of 80cents for anyone who holds less than 1000 shares, and then a reverse split makes them worthless. BOSC is setting up for a good quarter based on management comments (IMO) and it's also a low float so good numbers could easily blow this stock up.. ICPW is related to oil and gas sector so with rigs opening they should have a good quarter, a lot of the costs from last quarter made the net loss much higher than it should have been won't be dealt with this upcoming quarter

brb, buying 999 shares.

Ironclad is interesting. What makes you believe the BOSC management and Israeli GAAP?

Also, I'm warning you, don't miss out on CRDS (if you have the time to check the price during the day; this is a high maintenance trade), buy it tomorrow, and it should pop within a week. Hell, it may even pop Friday. Who knows? ;)

Choose your metrics, find companies with those metrics with a stock screener or by hand. Paid dividends for 10+ years, manageable debt, rising earning reports, undervalued, diversified business model, anything else you might be looking for. Look into the company in-depth because there is a reason it's undervalued. Maybe they had one bad earnings report and the market overreacted, maybe they are going through a temporary supply problem, maybe it's just the market being fickle and going through its natural fluctuations. I didn't know this stock was going to go up 27%, all you can do is buy good companies that are selling for less than their intristic value and hope for the best.

What should I read/learn to invest in the stock market? I read a random walk down wall street and it pretty much said to invest in an index fund

Look up Magic Formula Investing. It's a stock screener that supposedly finds the stocks most likely to make money over the next year.

Depends on what kind of investor you want to be. Ben Graham always says that 100% of your average investors should just buy an index fund. If you want to become an enterprising investor and try to outperform the market, know that you might not make it and you have to put in a lot of hours of effort.

Fuck, I mis-read your post. Read the Intelligent Investor.

Are you just spamming cramer tonight or what? the guy is garbage.

take it back

nope

>Tfw canacuck
>Own thousands of shares in alternative energy and weed stock
>Cost me a few hundo

C'mon baby. Give daddy hisbpay out